JPH0560819B2 - - Google Patents
Info
- Publication number
- JPH0560819B2 JPH0560819B2 JP4423986A JP4423986A JPH0560819B2 JP H0560819 B2 JPH0560819 B2 JP H0560819B2 JP 4423986 A JP4423986 A JP 4423986A JP 4423986 A JP4423986 A JP 4423986A JP H0560819 B2 JPH0560819 B2 JP H0560819B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- physiologically active
- culture
- formula
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 claims description 26
- 239000013543 active substance Substances 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 6
- 241000187747 Streptomyces Species 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 241000187180 Streptomyces sp. Species 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000005516 coenzyme A Substances 0.000 description 3
- 229940093530 coenzyme a Drugs 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical class O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000186984 Kitasatospora aureofaciens Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001138796 Streptomyces sp. SK 1894 Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000019646 color tone Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- UGGRVGVKANAYDM-UHFFFAOYSA-N nitrous hydrazide Chemical class NN=NO UGGRVGVKANAYDM-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- NKTGCVUIESDXPU-YLEPRARLSA-N triacsin C Chemical compound CCC\C=C\C\C=C\C=C\C=N\NN=O NKTGCVUIESDXPU-YLEPRARLSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4423986A JPS62205055A (ja) | 1986-03-03 | 1986-03-03 | 新規生理活性物質ｓｋ−１８９４およびその製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4423986A JPS62205055A (ja) | 1986-03-03 | 1986-03-03 | 新規生理活性物質ｓｋ−１８９４およびその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62205055A JPS62205055A (ja) | 1987-09-09 |
| JPH0560819B2 true JPH0560819B2 (no) | 1993-09-03 |
Family
ID=12685979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4423986A Granted JPS62205055A (ja) | 1986-03-03 | 1986-03-03 | 新規生理活性物質ｓｋ−１８９４およびその製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62205055A (no) |
-
1986
- 1986-03-03 JP JP4423986A patent/JPS62205055A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62205055A (ja) | 1987-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2127878C (en) | Fo-1289 substance and its production | |
| JP2993767B2 (ja) | Ｆｏ−１２８９ａ物質およびその製造法 | |
| JPH0560819B2 (no) | ||
| JP2710834B2 (ja) | Ｆｏ―６０８ａ物質およびその製造法 | |
| JP3434860B2 (ja) | Ｆｏ−２５４６物質およびその製造法 | |
| JP3074038B2 (ja) | Ｆｏ−１５１３ａ物質およびその製造法 | |
| JP2810752B2 (ja) | 新規生理活性物質サイクロオクタチン、その製造法およびその用途 | |
| WO2003097851A1 (fr) | Procede de production de derive d'acide alkylcarboxylique optiquement actif | |
| JP3858061B2 (ja) | 新規キチナーゼ阻害物質及びその製造法 | |
| JPH02306992A (ja) | 抗生物質ｒｋ―１０６１ｇ及びｒｋ―１０６１ｈ並びにその製造法 | |
| JP2872311B2 (ja) | Ｆｏ―６０８ｂ，ｃ物質およびその製造法 | |
| JPS6034550B2 (ja) | 酵素阻害物質ｋｍ−２７５３およびその製造法 | |
| JPH08198888A (ja) | ジヒドロフェナジン誘導体 | |
| JP3327982B2 (ja) | 新規な抗生物質ｍｉ４８１−４２ｆ４−ａ関連物質 | |
| JP2869486B2 (ja) | 光学活性（ｒ）‐（‐）‐３‐ハロ‐１，２‐プロパンジオールの製造法 | |
| JPH10310584A (ja) | 抗真菌化合物 | |
| JPWO2002081503A1 (ja) | 新規ｋ９７−０２３９物質およびその製造法 | |
| JPH0856688A (ja) | Ｆｏ−２５４６物質およびその製造法 | |
| JPH0631280B2 (ja) | Ｗｓ７７３９物質およびその製造法 | |
| JPS63246388A (ja) | 抗生物質ｒｓ−４４ｂ及びその製造法 | |
| JPS59156296A (ja) | Ｙ−０８３４ｈ−ｂ物質の製造法 | |
| JPH05239023A (ja) | 生理活性物質ｍｂｐ０３９−０６およびその製造法 | |
| JPS62207256A (ja) | ３，６−ジメトキシ−４−ヒドロキシ−１，２−ジメチルカルバゾ−ルおよびその製造法 | |
| JPH0710857A (ja) | 新規アルドース還元酵素阻害剤 | |
| JPH08198889A (ja) | ジヒドロフェナジン化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |